Enhancer-gene rewiring in the pathogenesis of Quebec platelet disorder.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
03 12 2020
Historique:
received: 28 04 2020
accepted: 06 07 2020
pubmed: 15 7 2020
medline: 7 4 2021
entrez: 15 7 2020
Statut: ppublish

Résumé

Quebec platelet disorder (QPD) is an autosomal dominant bleeding disorder with a unique, platelet-dependent, gain-of-function defect in fibrinolysis, without systemic fibrinolysis. The hallmark feature of QPD is a >100-fold overexpression of PLAU, specifically in megakaryocytes. This overexpression leads to a >100-fold increase in platelet stores of urokinase plasminogen activator (PLAU/uPA); subsequent plasmin-mediated degradation of diverse α-granule proteins; and platelet-dependent, accelerated fibrinolysis. The causative mutation is a 78-kb tandem duplication of PLAU. How this duplication causes megakaryocyte-specific PLAU overexpression is unknown. To investigate the mechanism that causes QPD, we used epigenomic profiling, comparative genomics, and chromatin conformation capture approaches to study PLAU regulation in cultured megakaryocytes from participants with QPD and unaffected controls. QPD duplication led to ectopic interactions between PLAU and a conserved megakaryocyte enhancer found within the same topologically associating domain (TAD). Our results support a unique disease mechanism whereby the reorganization of sub-TAD genome architecture results in a dramatic, cell-type-specific blood disorder phenotype.

Identifiants

pubmed: 32663239
pii: S0006-4971(20)81963-6
doi: 10.1182/blood.2020005394
pmc: PMC7735161
doi:

Substances chimiques

Membrane Proteins 0
PLAU protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2679-2690

Subventions

Organisme : CIHR
ID : 201603PJT-364832
Pays : Canada

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 by The American Society of Hematology.

Références

Cell. 2015 May 21;161(5):1012-1025
pubmed: 25959774
Science. 2016 Mar 25;351(6280):1454-1458
pubmed: 26940867
Methods Enzymol. 2012;513:89-112
pubmed: 22929766
Blood. 1999 Jan 15;93(2):500-8
pubmed: 9885211
Blood Adv. 2019 Jul 9;3(13):2045-2056
pubmed: 31289032
F1000Res. 2017 Mar 24;6:
pubmed: 28408976
Blood. 2009 Feb 12;113(7):1543-6
pubmed: 18988861
Int J Lab Hematol. 2018 Apr;40(2):e33-e34
pubmed: 29388746
Dev Dyn. 2005 Oct;234(2):244-54
pubmed: 16110506
J Thromb Haemost. 2013 Apr;11(4):593-604
pubmed: 23311859
Nat Methods. 2012 Oct;9(10):969-72
pubmed: 22961246
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Nat Immunol. 2003 Dec;4(12):1238-46
pubmed: 14608381
J Cell Biochem. 2009 Sep 1;108(1):35-42
pubmed: 19565566
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Bioinformatics. 2014 Oct;30(19):2808-10
pubmed: 24903420
Genome Biol. 2020 Jan 7;21(1):5
pubmed: 31910870
Nat Genet. 2016 Dec 28;49(1):5-6
pubmed: 28029156
J Biol Chem. 2007 Apr 27;282(17):12537-46
pubmed: 17331942
Blood. 2003 Aug 1;102(3):926-33
pubmed: 12689937
PLoS One. 2017 Mar 16;12(3):e0173991
pubmed: 28301587
Blood Coagul Fibrinolysis. 2008 Jul;19(5):463-4
pubmed: 18600101
Cell. 1983 Oct;34(3):779-87
pubmed: 6414718
Cell. 2014 Dec 18;159(7):1665-80
pubmed: 25497547
Nat Commun. 2017 Dec 5;8(1):1937
pubmed: 29203764
PLoS Genet. 2015 Dec 03;11(12):e1005640
pubmed: 26632825
Dev Cell. 2016 Mar 7;36(5):572-87
pubmed: 26923725
Cancer Cell. 2014 Apr 14;25(4):415-27
pubmed: 24703906
Nature. 2016 Oct 13;538(7624):265-269
pubmed: 27706140
Genome Res. 2012 Sep;22(9):1813-31
pubmed: 22955991
Nat Genet. 2017 Jan;49(1):65-74
pubmed: 27869826
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Genome Biol. 2014;15(12):550
pubmed: 25516281
Blood. 2004 Jul 1;104(1):159-65
pubmed: 15026313
PLoS Biol. 2010 Jan;8(1):e1000270
pubmed: 20052287
Genet Med. 2018 Jun;20(6):599-607
pubmed: 29236091
Blood. 2010 Feb 11;115(6):1264-6
pubmed: 20007542
Mol Cell. 2019 Jan 17;73(2):250-263.e5
pubmed: 30527662
Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
pubmed: 29126249
BMC Genomics. 2016 Mar 22;17:252
pubmed: 27004515
Nature. 2013 Nov 14;503(7475):290-4
pubmed: 24141950
Cell. 2014 Oct 9;159(2):374-387
pubmed: 25303531
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Blood. 1998 Nov 1;92(9):3025-34
pubmed: 9787135
Cell. 2016 Nov 17;167(5):1369-1384.e19
pubmed: 27863249
Cell. 2013 Jun 6;153(6):1281-95
pubmed: 23706625
Genes Dev. 2014 Oct 1;28(19):2151-62
pubmed: 25274727
Nature. 2012 Apr 11;485(7398):381-5
pubmed: 22495304
Genomics. 2013 Oct;102(4):250-6
pubmed: 23806289
Nat Protoc. 2008;3(1):59-69
pubmed: 18193022
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Blood. 2001 Jul 15;98(2):257-65
pubmed: 11435291
Cell. 2016 Nov 17;167(5):1188-1200
pubmed: 27863240
Methods. 2009 Jul;48(3):240-8
pubmed: 19275939
Genome Res. 2016 Jun;26(6):719-31
pubmed: 27053337
Cell. 2014 Apr 10;157(2):369-381
pubmed: 24703711
Dev Cell. 2011 May 17;20(5):597-609
pubmed: 21571218
Exp Hematol. 2004 Jul;32(7):638-48
pubmed: 15246160
Nat Commun. 2018 Nov 26;9(1):4977
pubmed: 30478328
Nature. 2012 Apr 11;485(7398):376-80
pubmed: 22495300
Blood. 2009 Feb 12;113(7):1535-42
pubmed: 19029443
Cell Rep. 2015 Mar 3;10(8):1297-309
pubmed: 25732821
Blood. 2018 Apr 19;131(16):1795-1804
pubmed: 29439951
Cell. 2015 Dec 17;163(7):1611-27
pubmed: 26686651
Cell. 2015 Mar 12;160(6):1049-59
pubmed: 25768903
Genes Dev. 2016 Dec 15;30(24):2657-2662
pubmed: 28087711
Nat Cell Biol. 2017 Aug;19(8):952-961
pubmed: 28737770
Dev Biol. 2010 Jan 15;337(2):484-95
pubmed: 19850031
Am J Hum Genet. 2016 Jan 7;98(1):185-201
pubmed: 26748519
Cell. 2012 Feb 3;148(3):458-72
pubmed: 22265598

Auteurs

Minggao Liang (M)

Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada.
Department of Molecular Genetics, The University of Toronto, Toronto, ON, Canada.

Asim Soomro (A)

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.

Subia Tasneem (S)

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.

Luis E Abatti (LE)

Department of Cell and Systems Biology and.

Azad Alizada (A)

Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada.
Department of Molecular Genetics, The University of Toronto, Toronto, ON, Canada.

Xuefei Yuan (X)

Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada.
Department of Molecular Genetics, The University of Toronto, Toronto, ON, Canada.

Liis Uusküla-Reimand (L)

Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada.

Lina Antounians (L)

Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada.
Department of Molecular Genetics, The University of Toronto, Toronto, ON, Canada.

Sana Akhtar Alvi (SA)

Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada.

Andrew D Paterson (AD)

Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada.
Dalla Lana School of Public Health and Institute of Medical Sciences, The University of Toronto, ON, Canada.

Georges-Étienne Rivard (GÉ)

Hematology/Oncology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC, Canada; and.

Ian C Scott (IC)

Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada.
Department of Molecular Genetics, The University of Toronto, Toronto, ON, Canada.

Jennifer A Mitchell (JA)

Department of Cell and Systems Biology and.

Catherine P M Hayward (CPM)

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
Hematology/Oncology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC, Canada; and.
Department of Medicine, McMaster University, Hamilton, ON, Canada.

Michael D Wilson (MD)

Program in Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada.
Department of Molecular Genetics, The University of Toronto, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH